Jump to content

5α-Reductase 2 deficiency

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Legobot (talk | contribs) at 04:49, 27 February 2013 (Bot: Migrating langlinks to WP:Wikidata - d:q858426). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

5α-Reductase 2 deficiency
SpecialtyMedical genetics Edit this on Wikidata

5α-Reductase deficiency (5-ARD) is an autosomal recessive intersex condition caused by a mutation of the 5α reductase type II gene.[1]

Normal function

5α-Reductase is an enzyme that converts testosterone to 5α-dihydrotestosterone (DHT) in peripheral tissues. These enzymes also participate in the creation of such neurosteroids as allopregnanolone and THDOC, convert progesterone into dihydroprogesterone (DHP), and convert deoxycorticosterone (DOC) into dihydrodeoxycorticosterone (DHDOC). 5-ARD is biochemically characterized by low to low-normal levels of testosterone and decreased levels of DHT, creating a higher testosterone/DHT ratio.

Biochemical effects of 5-ARD in testosterone biosynthesis. Levels of testosterone are elevated, while levels of DHT are significantly decreased, leading to male undervirilization.

DHT is a potent androgen, and is necessary for the development of male external genitalia in utero.

Signs

The condition affects only genetic males (that is, those with a Y-chromosome) because DHT has no known role in female development.[2]

Individuals with 5-ARD can have normal male external genitalia, ambiguous genitalia, or normal female genitalia. They are born with male gonads, including testicles and Wolffian structures, but usually have female primary sex characteristics. As a consequence, they are often raised as girls, but usually have a male gender identity.[3][4]

In general, individuals with 5-ARD are capable of producing viable sperm. In individuals with feminized or ambiguous genitalia, there is a tendency towards a macroclitoris or micropenis, and the urethra may attach to the phallus. This structure may be capable of ejaculations as well as erections, but may be insufficient for intercourse.

At puberty, individuals often have primary amenorrhoea and may experience virilization. This may include descending of the testes, hirsutism (facial/body hair considered normal in males - not to be confused with hypertrichosis), deepening of the voice, and enlargement of the clitoris. In adulthood, individuals do not experience male-pattern baldness.[1] As DHT is a far more potent androgen than testosterone alone, virilization in those lacking DHT may be absent or reduced compared to males with functional 5-AR. It is hypothesized that rising testosterone levels at the start of puberty (around age twelve) are able to generate sufficient levels of DHT either by the action of 5α-reductase type I (active in the adult liver, non-genital skin and some brain areas) or through the expression of low levels of 5α-reductase type II in the testes.

Infertility

There is an increased risk of cryptorchidism in 5-ARD, causing infertility, but also a higher risk of testicular cancer. Fertility is further compromised by the underdevelopment of seminal vesicles and prostate.

On the other hand, fertility depending on female characteristics is impossible; although the external genitalia may be female, the vagina consists of only the lower two-thirds of a normal vagina, creating a blind-ending vaginal pouch. Due to the normal action of Müllerian inhibiting factor produced by the testes in utero, individuals with 5-ARD lack a uterus and Fallopian tubes. Thus, individuals with 5-ARD are not able to carry a pregnancy, and, since they have testes and not ovaries, they are unable to create ova, which precludes such infertility treatments as surrogate motherhood.

Prevalence

The number of people with this condition varies relative to geographic location, depending on how much of a given population is interrelated.[citation needed] In a small remote village in the Dominican Republic 12 out of 13 families were affected. Here, the incidence was 1:90 males.[5]

In Popular Culture

In the Nip/Tuck season three episode "Quentin Costa", it is revealed that Dr. Quentin Costa had 5-ARD.

Jeffrey Eugenides' Pulitzer Prize-winning 2002 novel Middlesex is about a young man with 5-ARD. The character was originally born Calliope and raised as a girl, but upon realizing his true biological sex, he transitions into Cal. Eugenides himself does not have the deficiency.

See also

References

  1. ^ a b "5-alpha reductase deficiency". GPnotebook.
  2. ^ eMedicine article on 5-ARD
  3. ^ Praveen, EP (February 2008). "Gender identity of children and young adults with 5alpha-reductase deficiency". J Pediatr Endocrinol Metab. 21 (2) (2 ed.): 173–179. PMID 18422030. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  4. ^ Imperato-Mcginley, Julianne (May 31, 1979). "Androgens and the Evolution of Male-Gender Identity among Male Pseudohermaphrodites with 5α-Reductase Deficiency". New England Journal of Medicine. 300 (22): 1233–1237. doi:10.1056/NEJM197905313002201. PMID 431680. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  5. ^ Imperato-McGinley, Julianne; Guerrero, Luis; Gautier, Teofilo; Peterson, Ralph Edward (1974). "Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism". Science. 186 (4170): 1213–1215. doi:10.1126/science.186.4170.1213. PMID 4432067. {{cite journal}}: Unknown parameter |month= ignored (help)

External links


This template is no longer used; please see Template:Endocrine pathology for a suitable replacement